These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 8854891

  • 21. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X, Hagg T.
    J Comp Neurol; 1997 Nov 24; 388(3):484-94. PubMed ID: 9368855
    [Abstract] [Full Text] [Related]

  • 22. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA, Miller PJ, Collins F, Jiao S.
    Neuroscience; 1997 May 24; 78(1):61-72. PubMed ID: 9135089
    [Abstract] [Full Text] [Related]

  • 23. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease.
    Winkler C, Sauer H, Lee CS, Björklund A.
    J Neurosci; 1996 Nov 15; 16(22):7206-15. PubMed ID: 8929429
    [Abstract] [Full Text] [Related]

  • 24. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM, Gash DM.
    Brain Res; 1995 Feb 20; 672(1-2):104-11. PubMed ID: 7749731
    [Abstract] [Full Text] [Related]

  • 25. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
    Fox CM, Gash DM, Smoot MK, Cass WA.
    Brain Res; 2001 Mar 30; 896(1-2):56-63. PubMed ID: 11277973
    [Abstract] [Full Text] [Related]

  • 26. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.
    Yasuhara T, Shingo T, Muraoka K, Kobayashi K, Takeuchi A, Yano A, Wenji Y, Kameda M, Matsui T, Miyoshi Y, Date I.
    J Neurosurg; 2005 Jan 30; 102(1):80-9. PubMed ID: 15658100
    [Abstract] [Full Text] [Related]

  • 27. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.
    Palmer MR, Granholm AC, van Horne CG, Giardina KE, Freund RK, Moorhead JW, Gerhardt GA.
    Brain Res; 2001 Jan 26; 890(1):86-99. PubMed ID: 11164771
    [Abstract] [Full Text] [Related]

  • 28. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.
    Rosenblad C, Martinez-Serrano A, Björklund A.
    Neuroscience; 1998 Jan 26; 82(1):129-37. PubMed ID: 9483509
    [Abstract] [Full Text] [Related]

  • 29. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 26; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 30. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.
    Sortwell CE, Collier TJ, Sladek JR.
    J Comp Neurol; 1998 Oct 05; 399(4):530-40. PubMed ID: 9741481
    [Abstract] [Full Text] [Related]

  • 31. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M, Hoffer BJ, Olson L.
    J Neural Transplant Plast; 1997 Oct 05; 6(2):83-96. PubMed ID: 9306240
    [Abstract] [Full Text] [Related]

  • 32. Development of human fetal ventral mesencephalic grafts in rats with 6-OHDA lesions of the nigrostriatal pathway.
    Kondoh T, Pundt LL, Low WC.
    Neurosci Res; 1995 Jan 05; 21(3):223-33. PubMed ID: 7753503
    [Abstract] [Full Text] [Related]

  • 33. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y.
    Brain Res; 2001 Jun 15; 904(1):67-75. PubMed ID: 11516412
    [Abstract] [Full Text] [Related]

  • 34. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA, Araujo DM, Hilt DC, Sheng J, Jiao S.
    Brain Res; 1997 Nov 28; 777(1-2):153-60. PubMed ID: 9449424
    [Abstract] [Full Text] [Related]

  • 35. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.
    Georgievska B, Kirik D, Björklund A.
    Exp Neurol; 2002 Oct 28; 177(2):461-74. PubMed ID: 12429192
    [Abstract] [Full Text] [Related]

  • 36. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 37. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC.
    Exp Neurol; 1998 Dec 15; 154(2):261-75. PubMed ID: 9878166
    [Abstract] [Full Text] [Related]

  • 38. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 15; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 39. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway.
    Nikkhah G, Cunningham MG, Cenci MA, McKay RD, Björklund A.
    J Neurosci; 1995 May 15; 15(5 Pt 1):3548-61. PubMed ID: 7538563
    [Abstract] [Full Text] [Related]

  • 40. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 May 15; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.